Carcinogenesis Advance Access originally published online on February 10, 2006
Carcinogenesis 2006 27(5):893-902; doi:10.1093/carcin/bgi355
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW |
Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research
1 Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA and 2 Department of Food Science and Department of Human Nutrition, Michigan State University, East Lansing, MI 48824, USA
* To whom correspondence and requests for reprints should be addressed at: Cancer Prevention Fellowship Program, NCI, Division of Cancer Prevention, 6130 Executive Boulevard, MSC 7361 Bethesda, MD 20892-7361, USA Email: imigjeni{at}msu.edu
Clinical evidence reveals that the efficacy of dietary factors to prevent cancer is probably stage-dependent. The ability to demonstrate stage-specific effects of dietary compounds on normal, preneoplastic and malignant cell models may provide insights into puzzling clinical results from cancer chemoprevention trials. The relevance of these models to the field of cancer prevention is immense and will undoubtedly facilitate the ability to discover which dietary factors are most effective at preventing cancer and which, if any, specific steps in neoplastic transformation render cells refractory to the effects of dietary compounds. There are illustrative examples where exposure of high-risk individuals to dietary chemopreventive agents increases rather than decreases cancer risk. While geneticists and clinical oncologists acknowledge the morphological continuum along which tumors develop in specific tissues, tumor cells, rather than normal and preneoplastic cells, continue to be the primary in vitro reductionist tool employed to elucidate mechanisms underlying disease progression and to investigate the potential utility of dietary as well as other chemopreventive agents. Currently, there are few relevant model systems to study the progression of neoplastic transformation, especially in epithelial cells. We highlight examples of model systems isolated from prostate, breast, endometrial and intestinal tissue, with special emphasis on a specific set of non-tumorigenic, conditionally immortal cell lines derived from C57/BL6 mice [YAMC (Young Adult Mouse Colon cells; Apc+/+) cells and IMCE (Immorto-Min Colonic Epithelium cells; ApcMin/+) cells] that have yielded important information on early events in colorectal neoplasia development. These cell lines are an illustrative example of how researchers can examine stage-dependent effects of specific dietary components on carcinogenesis. The utilization of cell culture systems modeling early, middle and late stages of tumorigenesis will yield important insights into mechanisms by which dietary components impact cancer progression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Pierre, S. Tache, F. Gueraud, A.L. Rerole, M.-L. Jourdan, and C. Petit Apc mutation induces resistance of colonic cells to lipoperoxide-triggered apoptosis induced by faecal water from haem-fed rats Carcinogenesis, February 1, 2007; 28(2): 321 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Fenton, S. D. Hursting, S. N. Perkins, and N. G. Hord Leptin induces an Apc genotype-associated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation Carcinogenesis, February 1, 2007; 28(2): 455 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Fenton, S. D. Hursting, S. N. Perkins, and N. G. Hord Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line Carcinogenesis, July 1, 2006; 27(7): 1507 - 1515. [Abstract] [Full Text] [PDF]
|
|